Low-dose radiation is known to induce anti-inflammatory responses and has been historically used for treating infectious diseases such as pneumonia. As the outbreak of COVID-19 continues globally and effective treatment methods are lacking, low-dose radiation has drawn increasing attention recently. While some are optimistic about the clinical adoption of low-dose radiation for the treatment of COVID-19, others have significant concerns about its effectiveness and safety. This is the premise debated in this month's Point/Counterpoint.